{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:03:53Z","timestamp":1779869033827,"version":"3.53.1"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2022YFC3602000"],"award-info":[{"award-number":["2022YFC3602000"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274327"],"award-info":[{"award-number":["82274327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32141005"],"award-info":[{"award-number":["32141005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"DOI":"10.1186\/s13020-026-01426-9","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:18:09Z","timestamp":1779866289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the gut\u2012kidney axis for lupus nephritis treatment: multimechanism regulatory strategies and evidence from Traditional Chinese medicine"],"prefix":"10.1186","volume":"21","author":[{"given":"Qingyun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"1426_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"H-J Anders","year":"2020","unstructured":"Anders H-J, Saxena R, Zhao M, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6:7. https:\/\/doi.org\/10.1038\/s41572-019-0141-9.","journal-title":"Nat Rev Dis Primers"},{"key":"1426_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76:265\u201381. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.017.","journal-title":"Am J Kidney Dis"},{"key":"1426_CR3","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.autrev.2022.103211","volume":"21","author":"LE Kwant","year":"2022","unstructured":"Kwant LE, Vegting Y, Tsang-a-Sjoe MWP, Kwakernaak AJ, Vogt L, Voskuyl AE, et al. Macrophages in lupus nephritis: exploring a potential new therapeutic avenue. Autoimmun Rev. 2022;21:103211. https:\/\/doi.org\/10.1016\/j.autrev.2022.103211.","journal-title":"Autoimmun Rev"},{"key":"1426_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diagnostics15010021","volume":"15","author":"K Tsuji","year":"2024","unstructured":"Tsuji K, Uchida N, Nakanoh H, Fukushima K, Haraguchi S, Kitamura S, et al. The gut\u2013kidney axis in chronic kidney diseases. Diagnostics. 2024;15:21. https:\/\/doi.org\/10.3390\/diagnostics15010021.","journal-title":"Diagnostics"},{"key":"1426_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7150\/ijbs.125140","volume":"22","author":"Y Jin","year":"2026","unstructured":"Jin Y, Zhang S-J, Zhuang S, Li P, Miao H, Zhao Y-Y. Microbiota-gut-kidney axis in health and renal disease. Int J Biol Sci. 2026;22:750\u201370. https:\/\/doi.org\/10.7150\/ijbs.125140.","journal-title":"Int J Biol Sci"},{"key":"1426_CR6","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3390\/nu17121961","volume":"17","author":"S Wakino","year":"2025","unstructured":"Wakino S, Hasegawa K, Tamaki M, Minato M, Inagaki T. Kidney-gut axis in chronic kidney disease: therapeutic perspectives from microbiota modulation and nutrition. Nutrients. 2025;17:1961. https:\/\/doi.org\/10.3390\/nu17121961.","journal-title":"Nutrients"},{"key":"1426_CR7","doi-asserted-by":"publisher","first-page":"105135","DOI":"10.1016\/j.phrs.2020.105135","volume":"161","author":"P Dey","year":"2020","unstructured":"Dey P. Targeting gut barrier dysfunction with phytotherapies: effective strategy against chronic diseases. Pharmacol Res. 2020;161:105135. https:\/\/doi.org\/10.1016\/j.phrs.2020.105135.","journal-title":"Pharmacol Res"},{"key":"1426_CR8","doi-asserted-by":"publisher","first-page":"115183","DOI":"10.1016\/j.biopha.2023.115183","volume":"165","author":"A Balkrishna","year":"2023","unstructured":"Balkrishna A, Sinha S, Kumar A, Arya V, Gautam AK, Valis M, et al. Sepsis-mediated renal dysfunction: pathophysiology, biomarkers and role of phytoconstituents in its management. Biomed Pharmacother. 2023;165:115183. https:\/\/doi.org\/10.1016\/j.biopha.2023.115183.","journal-title":"Biomed Pharmacother"},{"key":"1426_CR9","doi-asserted-by":"publisher","first-page":"2285877","DOI":"10.1080\/0886022X.2023.2285877","volume":"45","author":"A Wang","year":"2023","unstructured":"Wang A, Zhao J, Qin Y, Zhang Y, Xing Y, Wang Y, et al. Alterations of the gut microbiota in the lupus nephritis: a systematic review. Ren Fail. 2023;45:2285877. https:\/\/doi.org\/10.1080\/0886022X.2023.2285877.","journal-title":"Ren Fail"},{"key":"1426_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156\u201361. https:\/\/doi.org\/10.1126\/science.aar7201.","journal-title":"Science"},{"key":"1426_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11658-025-00716-8","volume":"30","author":"Q Pan","year":"2025","unstructured":"Pan Q, Guo F, Chen J, Huang H, Huang Y, Liao S, et al. Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL\/lpr mice. Cell Mol Biol Lett. 2025;30:49. https:\/\/doi.org\/10.1186\/s11658-025-00716-8.","journal-title":"Cell Mol Biol Lett"},{"key":"1426_CR12","doi-asserted-by":"publisher","first-page":"112799","DOI":"10.1016\/j.biopha.2022.112799","volume":"149","author":"Y-J Wang","year":"2022","unstructured":"Wang Y-J, Li Y-X, Li S, He W, Wang Z-R, Zhan T-P, et al. Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis. Biomed Pharmacother. 2022;149:112799. https:\/\/doi.org\/10.1016\/j.biopha.2022.112799.","journal-title":"Biomed Pharmacother"},{"key":"1426_CR13","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u20136. https:\/\/doi.org\/10.1093\/nar\/gkae973.","journal-title":"Nucleic Acids Res"},{"key":"1426_CR14","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B. The gut\u2013kidney axis. Pediatr Nephrol. 2017;32:2005\u201314. https:\/\/doi.org\/10.1007\/s00467-016-3527-x.","journal-title":"Pediatr Nephrol"},{"key":"1426_CR15","doi-asserted-by":"publisher","first-page":"1671036","DOI":"10.3389\/fmed.2025.1671036","volume":"12","author":"Z Li","year":"2025","unstructured":"Li Z, Yang S, Zhou X, Qing Y, Zhang T, Xu W, et al. Alterations in gut\u2013kidney axis indicators and TMAO-related biomarkers in elderly patients with hypertensive nephropathy. Front Med. 2025;12:1671036. https:\/\/doi.org\/10.3389\/fmed.2025.1671036.","journal-title":"Front Med"},{"key":"1426_CR16","doi-asserted-by":"publisher","first-page":"1602235","DOI":"10.3389\/fimmu.2025.1602235","volume":"16","author":"DN Habiballah","year":"2025","unstructured":"Habiballah DN, Li F, Jiang L. Immune metabolic restoration in systemic lupus erythematosus: the impact of gut microbiota, probiotics, and nutritional synergy. Front Immunol. 2025;16:1602235. https:\/\/doi.org\/10.3389\/fimmu.2025.1602235.","journal-title":"Front Immunol"},{"key":"1426_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"T Yang","year":"2018","unstructured":"Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain\u2013gut\u2013kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14:442\u201356. https:\/\/doi.org\/10.1038\/s41581-018-0018-2.","journal-title":"Nat Rev Nephrol"},{"key":"1426_CR18","doi-asserted-by":"publisher","first-page":"919792","DOI":"10.3389\/fimmu.2022.919792","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma L, Morel L. Loss of gut barrier integrity in lupus. Front Immunol. 2022;13:919792. https:\/\/doi.org\/10.3389\/fimmu.2022.919792.","journal-title":"Front Immunol"},{"key":"1426_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11926-023-01115-8","volume":"25","author":"FNC Kalayci","year":"2023","unstructured":"Kalayci FNC, Ozen S. Possible role of dysbiosis of the gut microbiome in SLE. Curr Rheumatol Rep. 2023;25:247\u201358. https:\/\/doi.org\/10.1007\/s11926-023-01115-8.","journal-title":"Curr Rheumatol Rep"},{"key":"1426_CR20","doi-asserted-by":"publisher","first-page":"102867","DOI":"10.1016\/j.jaut.2022.102867","volume":"132","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lin J, Xiao L, Zhang X, Zhao L, Wang M, et al. Gut microbiota in systemic lupus erythematosus: a fuse and a solution. J Autoimmun. 2022;132:102867. https:\/\/doi.org\/10.1016\/j.jaut.2022.102867.","journal-title":"J Autoimmun"},{"key":"1426_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.phrs.2019.02.024","volume":"142","author":"W Feng","year":"2019","unstructured":"Feng W, Ao H, Peng C, Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019;142:176\u201391. https:\/\/doi.org\/10.1016\/j.phrs.2019.02.024.","journal-title":"Pharmacol Res"},{"key":"1426_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41385-019-0192-y","volume":"13","author":"D Sterlin","year":"2020","unstructured":"Sterlin D, Fadlallah J, Slack E, Gorochov G. The antibody\/microbiota interface in health and disease. Mucosal Immunol. 2020;13:3\u201311. https:\/\/doi.org\/10.1038\/s41385-019-0192-y.","journal-title":"Mucosal Immunol"},{"key":"1426_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","volume":"14","author":"UM M\u00f6rbe","year":"2021","unstructured":"M\u00f6rbe UM, J\u00f8rgensen PB, Fenton TM, Von Burg N, Riis LB, Spencer J, et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 2021;14:793\u2013802. https:\/\/doi.org\/10.1038\/s41385-021-00389-4.","journal-title":"Mucosal Immunol"},{"key":"1426_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark M, Pitcher MJ, Dionisi C, Spencer J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol. 2024;45:211\u201323. https:\/\/doi.org\/10.1016\/j.it.2024.01.006.","journal-title":"Trends Immunol"},{"key":"1426_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WHW Tang","year":"2015","unstructured":"Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N -oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448\u201355. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305360.","journal-title":"Circ Res"},{"key":"1426_CR26","doi-asserted-by":"publisher","first-page":"1430356","DOI":"10.3389\/fimmu.2024.1430356","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Xu Y, Sun T, Zhang X, Liang H, Lin W, et al. Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota. Front Immunol. 2024;15:1430356. https:\/\/doi.org\/10.3389\/fimmu.2024.1430356.","journal-title":"Front Immunol"},{"key":"1426_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/microorganisms13020445","volume":"13","author":"E Parodi","year":"2025","unstructured":"Parodi E, Novi M, Bottino P, La Porta E, Merlotti G, Castello LM, et al. The complex role of gut microbiota in systemic lupus erythematosus and lupus nephritis: from pathogenetic factor to therapeutic target. Microorganisms. 2025;13:445. https:\/\/doi.org\/10.3390\/microorganisms13020445.","journal-title":"Microorganisms"},{"key":"1426_CR28","doi-asserted-by":"publisher","first-page":"883747","DOI":"10.3389\/fimmu.2022.883747","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Fan Y, Wang X. Lactobacillus: friend or foe for systemic lupus erythematosus? Front Immunol. 2022;13:883747. https:\/\/doi.org\/10.3389\/fimmu.2022.883747.","journal-title":"Front Immunol"},{"key":"1426_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12016-025-09093-8","volume":"68","author":"EJ Han","year":"2025","unstructured":"Han EJ, Ahn J-S, Chae YJ, Chung H-J. Immunomodulatory roles of Faecalibacterium prausnitzii and Akkermansia muciniphila in autoimmune diseases: mechanistic insights and therapeutic potential. Clin Rev Allergy Immunol. 2025;68:77. https:\/\/doi.org\/10.1007\/s12016-025-09093-8.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1426_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2017.03.009","volume":"83","author":"B Chen","year":"2017","unstructured":"Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun. 2017;83:31\u201342. https:\/\/doi.org\/10.1016\/j.jaut.2017.03.009.","journal-title":"J Autoimmun"},{"key":"1426_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12016-025-09051-4","volume":"68","author":"L Jin","year":"2025","unstructured":"Jin L, Xiao J, Luo Y, Duan L, Gong Y, Li Y, et al. Exploring gut microbiota in Systemic Lupus Erythematosus: insights and biomarker discovery potential. Clin Rev Allergy Immunol. 2025;68:42. https:\/\/doi.org\/10.1007\/s12016-025-09051-4.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1426_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","volume":"5","author":"Q Mu","year":"2017","unstructured":"Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. Control of Lupus nephritis by changes of gut microbiota. Microbiome. 2017;5:73. https:\/\/doi.org\/10.1186\/s40168-017-0300-8.","journal-title":"Microbiome"},{"key":"1426_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10020-019-0102-5","volume":"25","author":"Y Ma","year":"2019","unstructured":"Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of Systemic Lupus Erythematosus. Mol Med. 2019;25:35. https:\/\/doi.org\/10.1186\/s10020-019-0102-5.","journal-title":"Mol Med"},{"key":"1426_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","volume":"159","author":"DM Chopyk","year":"2020","unstructured":"Chopyk DM, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology. 2020;159:849\u201363. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.077.","journal-title":"Gastroenterology"},{"key":"1426_CR35","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia A, Milani C, L\u00f3pez P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5:e01548-14. https:\/\/doi.org\/10.1128\/mBio.01548-14.","journal-title":"mBio"},{"key":"1426_CR36","doi-asserted-by":"publisher","first-page":"104367","DOI":"10.1016\/j.phrs.2019.104367","volume":"147","author":"P Dey","year":"2019","unstructured":"Dey P. Gut microbiota in phytopharmacology: a comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacol Res. 2019;147:104367. https:\/\/doi.org\/10.1016\/j.phrs.2019.104367.","journal-title":"Pharmacol Res"},{"key":"1426_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78:947\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214856.","journal-title":"Ann Rheum Dis"},{"key":"1426_CR38","doi-asserted-by":"publisher","first-page":"686501","DOI":"10.3389\/fimmu.2021.686501","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in Systemic Lupus Erythematosus: link, mechanisms and intervention. Front Immunol. 2021;12:686501. https:\/\/doi.org\/10.3389\/fimmu.2021.686501.","journal-title":"Front Immunol"},{"key":"1426_CR39","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/biom15111586","volume":"15","author":"R Ishihara","year":"2025","unstructured":"Ishihara R, Watanabe R, Shiomi M, Fujita Y, Katsushima M, Fukumoto K, et al. The type I interferon axis in systemic autoimmune diseases: from molecular pathways to targeted therapy. Biomolecules. 2025;15:1586. https:\/\/doi.org\/10.3390\/biom15111586.","journal-title":"Biomolecules"},{"key":"1426_CR40","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41467-023-37419-7","volume":"14","author":"P Tian","year":"2023","unstructured":"Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat Commun. 2023;14:1710. https:\/\/doi.org\/10.1038\/s41467-023-37419-7.","journal-title":"Nat Commun"},{"key":"1426_CR41","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1021\/acs.jafc.4c00263","volume":"72","author":"H-W Huang","year":"2024","unstructured":"Huang H-W, Chen M-J. Exploring the preventive and therapeutic mechanisms of probiotics in chronic kidney disease through the gut\u2013kidney axis. J Agric Food Chem. 2024;72:8347\u201364. https:\/\/doi.org\/10.1021\/acs.jafc.4c00263.","journal-title":"J Agric Food Chem"},{"key":"1426_CR42","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1126\/science.abd8344","volume":"369","author":"JL Pluznick","year":"2020","unstructured":"Pluznick JL. The gut microbiota in kidney disease. Science. 2020;369:1426\u20137. https:\/\/doi.org\/10.1126\/science.abd8344.","journal-title":"Science"},{"key":"1426_CR43","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.clnu.2018.11.029","volume":"38","author":"C-Y Sun","year":"2019","unstructured":"Sun C-Y, Lin C-J, Pan H-C, Lee C-C, Lu S-C, Hsieh Y-T, et al. Clinical association between the metabolite of healthy gut microbiota, 3-indolepropionic acid and chronic kidney disease. Clin Nutr. 2019;38:2945\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2018.11.029.","journal-title":"Clin Nutr"},{"key":"1426_CR44","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R, Kerckhof F-M, Van Biesen W, Van De Wiele T, et al. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int. 2020;97:1230\u201342. https:\/\/doi.org\/10.1016\/j.kint.2020.01.028.","journal-title":"Kidney Int"},{"key":"1426_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, \u0141awi\u0144ski J, Olszewski R, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. The impact of CKD on uremic toxins and gut microbiota. Toxins Basel. 2021;13:252. https:\/\/doi.org\/10.3390\/toxins13040252.","journal-title":"Toxins Basel"},{"key":"1426_CR46","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3389\/fimmu.2018.02836","volume":"9","author":"J Rauch","year":"2018","unstructured":"Rauch J, Salem D, Subang R, Kuwana M, Levine JS. \u03b22-glycoprotein I-reactive T cells in autoimmune disease. Front Immunol. 2018;9:2836. https:\/\/doi.org\/10.3389\/fimmu.2018.02836.","journal-title":"Front Immunol"},{"key":"1426_CR47","doi-asserted-by":"publisher","first-page":"eaan2306","DOI":"10.1126\/scitranslmed.aan2306","volume":"10","author":"TM Greiling","year":"2018","unstructured":"Greiling TM, Dehner C, Chen X, Hughes K, I\u00f1iguez AJ, Boccitto M, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10:eaan2306. https:\/\/doi.org\/10.1126\/scitranslmed.aan2306.","journal-title":"Sci Transl Med"},{"key":"1426_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-021-00986-z","volume":"23","author":"R Li","year":"2021","unstructured":"Li R, Meng X, Chen B, Zhao L, Zhang X. Gut microbiota in lupus: a butterfly effect? Curr Rheumatol Rep. 2021;23:27. https:\/\/doi.org\/10.1007\/s11926-021-00986-z.","journal-title":"Curr Rheumatol Rep"},{"key":"1426_CR49","doi-asserted-by":"publisher","first-page":"620102","DOI":"10.3389\/fmed.2020.620102","volume":"7","author":"E Stavropoulou","year":"2021","unstructured":"Stavropoulou E, Kantartzi K, Tsigalou C, Konstantinidis T, Romanidou G, Voidarou C, et al. Focus on the gut\u2013kidney axis in health and disease. Front Med. 2021;7:620102. https:\/\/doi.org\/10.3389\/fmed.2020.620102.","journal-title":"Front Med"},{"key":"1426_CR50","doi-asserted-by":"publisher","first-page":"1620247","DOI":"10.3389\/fmed.2025.1620247","volume":"12","author":"Q Wang","year":"2025","unstructured":"Wang Q, Han Y, Pang L, Zhou Z, Dai L. Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions. Front Med. 2025;12:1620247. https:\/\/doi.org\/10.3389\/fmed.2025.1620247.","journal-title":"Front Med"},{"key":"1426_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5687","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Zhao Q, Zhang S, Liu J, Fan X, Han B, et al. Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation (review). Int J Mol Med. 2025;57:1\u201329. https:\/\/doi.org\/10.3892\/ijmm.2025.5687.","journal-title":"Int J Mol Med"},{"key":"1426_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.11842\/wst.20250815003","volume":"28","author":"L Zhang","year":"2026","unstructured":"Zhang L, Wang Y, Lu T, Zhan L. Analysis of the intestinal-immune axis mechanism mediated of aging by the imbalance of multidimensional barrier homeostasis in intestinal mucosa based on the theory of \u201cSpleen being in charge of the defensive function.\u201d Mod Tradit Chin Med Mater Med World Sci Technol. 2026;28:364\u201373. https:\/\/doi.org\/10.11842\/wst.20250815003.","journal-title":"Mod Tradit Chin Med Mater Med World Sci Technol"},{"key":"1426_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.13422\/j.cnki.syfjx.20230498","volume":"29","author":"X Li","year":"2023","unstructured":"Li X, Ma H, Ma H, Wei J. Intervention of renal fibrosis with traditional chinese medicine by regulating intestinal microecology based on \u201cCombination of state and target.\u201d Chin J Exp Tradit Med Formulae. 2023;29:185\u201391. https:\/\/doi.org\/10.13422\/j.cnki.syfjx.20230498.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"1426_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/antiox11010084","volume":"11","author":"C Gonz\u00e1lez-Correa","year":"2021","unstructured":"Gonz\u00e1lez-Correa C, Mole\u00f3n J, Mi\u00f1ano S, Visitaci\u00f3n NDL, Robles-Vera I, G\u00f3mez-Guzm\u00e1n M, et al. Trimethylamine N-oxide promotes autoimmunity and a loss of vascular function in toll-like receptor 7-driven lupus mice. Antioxidants Basel. 2021;11:84. https:\/\/doi.org\/10.3390\/antiox11010084.","journal-title":"Antioxidants Basel"},{"key":"1426_CR55","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.16368\/j.issn.1674-8999.2024.07.228","volume":"39","author":"H Wang","year":"2024","unstructured":"Wang H, Huang G, Chen Y, Liu S, Mo C. Research progress on treatment of diabetic kidney disease from spleen and stomach in TCM based on gut microbiota. Acta Chin Med. 2024;39:1374\u201383. https:\/\/doi.org\/10.16368\/j.issn.1674-8999.2024.07.228.","journal-title":"Acta Chin Med"},{"key":"1426_CR56","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.13359\/j.cnki.gzxbtcm.2023.11.001","volume":"40","author":"X-Y Chen","year":"2023","unstructured":"Chen X-Y, Chen G-H, Yang L-H, Liu S-N, Zhang L, Mao W, et al. Study on the correlation between damp-heat syndrome and microinflammation in diabetic kidney disease. J Guangzhou Univ Tradit Chin Med. 2023;40:2689\u201396. https:\/\/doi.org\/10.13359\/j.cnki.gzxbtcm.2023.11.001.","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"1426_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1142\/S0192415X26500035","volume":"54","author":"Y Gong","year":"2026","unstructured":"Gong Y, Zhao N, Liu Y. Research progress on traditional Chinese medicine in regulating inflammatory pathways of the gut\u2013kidney axis in diabetic kidney disease. Am J Chin Med. 2026;54:87\u2013116. https:\/\/doi.org\/10.1142\/S0192415X26500035.","journal-title":"Am J Chin Med"},{"key":"1426_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2016.04.007","volume":"179","author":"A Nallu","year":"2017","unstructured":"Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D. Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res. 2017;179:24\u201337. https:\/\/doi.org\/10.1016\/j.trsl.2016.04.007.","journal-title":"Transl Res"},{"key":"1426_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8:129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Signal Transduct Target Ther"},{"key":"1426_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita N, Kramann R. Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol Metab. 2024;35:31\u201348. https:\/\/doi.org\/10.1016\/j.tem.2023.09.001.","journal-title":"Trends Endocrinol Metab"},{"key":"1426_CR61","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/toxins17120599","volume":"17","author":"Y Xin","year":"2025","unstructured":"Xin Y, Pan L. Targeting the gut\u2013kidney axis: modulation of gut microbiota by traditional Chinese medicine for chronic kidney disease management. Toxins Basel. 2025;17:599. https:\/\/doi.org\/10.3390\/toxins17120599.","journal-title":"Toxins Basel"},{"key":"1426_CR62","first-page":"1458","volume":"37","author":"K Chen","year":"2022","unstructured":"Chen K, Wang X, Lu G, Li Z, Fan Y. FAN Yong-sheng\u2019s academic experience in treating Lupus nephritis. CJTCMP. 2022;37:1458\u201361.","journal-title":"CJTCMP"},{"key":"1426_CR63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.16368\/j.issn.1674-8999.2026.03.065","volume":"41","author":"C Song","year":"2026","unstructured":"Song C. Traditional Chinese medicine diagnosis and treatment thinking for chronic kidney disease based on disease-syndrome combination. Acta Chin Med. 2026;41:453\u20137. https:\/\/doi.org\/10.16368\/j.issn.1674-8999.2026.03.065.","journal-title":"Acta Chin Med"},{"key":"1426_CR64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3969\/j.issn.1000-7369.2026.03.017","volume":"47","author":"Q Lyu","year":"2026","unstructured":"Lyu Q, Zhong J. Clinical application of the traditional Chinese medicine theory of turbid evil impairing clarity in chronic kidney disease. Shaanxi J Tradit Chin Med. 2026;47:379\u201383. https:\/\/doi.org\/10.3969\/j.issn.1000-7369.2026.03.017.","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"1426_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3969\/j.issn.1005-5304.201903372","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Jiang Z, Dong N. Discussion on the mechanism of treating chronic kidney disease from spleen based on intestinal microecology and \u201cintestinal-kidney axis\u201d theory. Chinese J Inf TCM. 2020;27:14\u20137. https:\/\/doi.org\/10.3969\/j.issn.1005-5304.201903372.","journal-title":"Chinese J Inf TCM"},{"key":"1426_CR66","doi-asserted-by":"publisher","first-page":"123767","DOI":"10.1016\/j.ijbiomac.2023.123767","volume":"234","author":"B Yang","year":"2023","unstructured":"Yang B, Xiong Z, Lin M, Yang Y, Chen Y, Zeng J, et al. Astragalus polysaccharides alleviate type 1 diabetes via modulating gut microbiota in mice. Int J Biol Macromol. 2023;234:123767. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123767.","journal-title":"Int J Biol Macromol"},{"key":"1426_CR67","doi-asserted-by":"publisher","first-page":"1068613","DOI":"10.3389\/fphar.2022.1068613","volume":"13","author":"L Zheng","year":"2023","unstructured":"Zheng L, Luo M, Zhou H, Chen J. Natural products from plants and microorganisms: novel therapeutics for chronic kidney disease via gut microbiota regulation. Front Pharmacol. 2023;13:1068613. https:\/\/doi.org\/10.3389\/fphar.2022.1068613.","journal-title":"Front Pharmacol"},{"key":"1426_CR68","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.19945\/j.cnki.issn.1006-3250.2018.11.018","volume":"24","author":"J Shen","year":"2018","unstructured":"Shen J, Hu F, Huang W. Discussion on the relationship between TCM pathogenesis of renal fibrosis and Wnt\/beta-catenin signaling pathway. J Basic Chin Med. 2018;24:1548\u20139. https:\/\/doi.org\/10.19945\/j.cnki.issn.1006-3250.2018.11.018.","journal-title":"J Basic Chin Med"},{"key":"1426_CR69","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/ddr.22096","volume":"84","author":"J Liu","year":"2023","unstructured":"Liu J, Liu S, Yu M, Li J, Xie Z, Gao B, et al. Anti\u2010inflammatory effect and mechanism of catalpol in various inflammatory diseases. Drug Dev Res. 2023;84:1376\u201394. https:\/\/doi.org\/10.1002\/ddr.22096.","journal-title":"Drug Dev Res"},{"key":"1426_CR70","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3969\/j.issn.1673-7202.2024.22.018","volume":"19","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wang Y, Liu M, Zhao W, Xie J. Effect of Dampness in the occurrence and development of chronic kidney disease based on brain-gut-kidney Axi. World Chin Med. 2024;19:3531\u20135. https:\/\/doi.org\/10.3969\/j.issn.1673-7202.2024.22.018.","journal-title":"World Chin Med"},{"key":"1426_CR71","doi-asserted-by":"publisher","first-page":"1267091","DOI":"10.3389\/fimmu.2023.1267091","volume":"14","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Zhang M, Jiang D, Su Q, Shi J. The role of inflammation in autoimmune disease: a therapeutic target. Front Immunol. 2023;14:1267091. https:\/\/doi.org\/10.3389\/fimmu.2023.1267091.","journal-title":"Front Immunol"},{"key":"1426_CR72","doi-asserted-by":"publisher","first-page":"157030","DOI":"10.1016\/j.phymed.2025.157030","volume":"146","author":"W Zhou","year":"2025","unstructured":"Zhou W, Asif A, Situ C, Wang J, Hao H. Multiple target and regulatory pathways of berberine. Phytomedicine. 2025;146:157030. https:\/\/doi.org\/10.1016\/j.phymed.2025.157030.","journal-title":"Phytomedicine"},{"key":"1426_CR73","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.13935\/j.cnki.sjzx.240636","volume":"19","author":"Y Qin","year":"2024","unstructured":"Qin Y, Lyu J, Zhan L, Zhan L. Pathogenesis of renal fibrosis based on \u201cCollateral-vascular system.\u201d World J Integr Tradit West Med. 2024;19:1256\u20139. https:\/\/doi.org\/10.13935\/j.cnki.sjzx.240636.","journal-title":"World J Integr Tradit West Med"},{"key":"1426_CR74","doi-asserted-by":"publisher","first-page":"6","DOI":"10.19879\/j.cnki.1005-5304.202203242","volume":"30","author":"Y Fu","year":"2023","unstructured":"Fu Y, Jin Z, Jin C, Chen Y, Jiang X, Zhang B. Discussion on treatment of diabetic glomerulosclerosis from Huoxue Huayu method based on intestinal microecology. Zhongguo Zhong Yi Yao Xin Xi Za Zhi. 2023;30:6\u201310. https:\/\/doi.org\/10.19879\/j.cnki.1005-5304.202203242.","journal-title":"Zhongguo Zhong Yi Yao Xin Xi Za Zhi"},{"key":"1426_CR75","doi-asserted-by":"publisher","first-page":"917975","DOI":"10.3389\/fphar.2022.917975","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Feng Y, Li M, Yang M, Shi G, Xuan Z, et al. Traditional Chinese medicine in the treatment of chronic kidney diseases: theories, applications, and mechanisms. Front Pharmacol. 2022;13:917975. https:\/\/doi.org\/10.3389\/fphar.2022.917975.","journal-title":"Front Pharmacol"},{"key":"1426_CR76","doi-asserted-by":"publisher","first-page":"1642377","DOI":"10.3389\/fmicb.2025.1642377","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, Diao L, Li M, Huang F, Sun K. Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease. Front Microbiol. 2025;16:1642377. https:\/\/doi.org\/10.3389\/fmicb.2025.1642377.","journal-title":"Front Microbiol"},{"key":"1426_CR77","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/pharmaceutics15092235","volume":"15","author":"G He","year":"2023","unstructured":"He G, Chen G, Liu W, Ye D, Liu X, Liang X, et al. Salvianolic acid B: a review of pharmacological effects, safety, combination therapy, new dosage forms, and novel drug delivery routes. Pharmaceutics. 2023;15:2235. https:\/\/doi.org\/10.3390\/pharmaceutics15092235.","journal-title":"Pharmaceutics"},{"key":"1426_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.16305\/j.1007-1334.2024.z20240621009","volume":"58","author":"A Qian","year":"2024","unstructured":"Qian A, Huang C, Zhu Y, Cheng Y, Hu K. Exploring feasibility of strengthening spleen and nourishing kidney method in regulating intestinal microflora in treatment of systemic lupus erythematosus based on \u201ckidney-spleen-intestine axis\u201d theory. Shanghai Zhong Yi Yao Za Zhi. 2024;58:52\u20135+70. https:\/\/doi.org\/10.16305\/j.1007-1334.2024.z20240621009.","journal-title":"Shanghai Zhong Yi Yao Za Zhi"},{"key":"1426_CR79","doi-asserted-by":"publisher","first-page":"116257","DOI":"10.1016\/j.jep.2023.116257","volume":"307","author":"C Han","year":"2023","unstructured":"Han C, Shen Z, Cui T, Ai S, Gao R, Liu Y, et al. Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the \u201cgut-kidney axis.\u201d J Ethnopharmacol. 2023;307:116257. https:\/\/doi.org\/10.1016\/j.jep.2023.116257.","journal-title":"J Ethnopharmacol"},{"key":"1426_CR80","doi-asserted-by":"publisher","first-page":"157412","DOI":"10.1016\/j.phymed.2025.157412","volume":"148","author":"W Liu","year":"2025","unstructured":"Liu W, Zhang Y, Gu S, Zhang L, Cai Y, Mo Y, et al. Bupi yishen formula against chronic kidney injury via Akkermansia muciniphila mediated group 3 innate lymphoid cells activation to repair intestinal barrier funciton. Phytomedicine. 2025;148:157412. https:\/\/doi.org\/10.1016\/j.phymed.2025.157412.","journal-title":"Phytomedicine"},{"key":"1426_CR81","doi-asserted-by":"publisher","first-page":"119197","DOI":"10.1016\/j.jep.2024.119197","volume":"340","author":"J-C Liao","year":"2025","unstructured":"Liao J-C, Xiang J, Gui W-Y, Luo H-Z, You Q, He Q-R, et al. Broad range lipidomics and metabolomics coupled with 16S rRNA sequencing to reveal the mechanisms of huangkui capsule against cisplatin-induced nephrotoxicity. J Ethnopharmacol. 2025;340:119197. https:\/\/doi.org\/10.1016\/j.jep.2024.119197.","journal-title":"J Ethnopharmacol"},{"key":"1426_CR82","doi-asserted-by":"publisher","first-page":"1526863","DOI":"10.3389\/fcimb.2025.1526863","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu J, Dai W, Yang S. Jian-pi-yi-shen formula improves kidney function by regulating gut microbiome in rats with chronic kidney disease. Front Cell Infect Microbiol. 2025;15:1526863. https:\/\/doi.org\/10.3389\/fcimb.2025.1526863.","journal-title":"Front Cell Infect Microbiol"},{"key":"1426_CR83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13880209.2024.2345080","volume":"62","author":"X Dong","year":"2024","unstructured":"Dong X, Zhang J, Li W, Li Y, Jia L, Liu Z, et al. Yi-shen-hua-shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharm Biol. 2024;62:356\u201366. https:\/\/doi.org\/10.1080\/13880209.2024.2345080.","journal-title":"Pharm Biol"},{"key":"1426_CR84","doi-asserted-by":"publisher","first-page":"155129","DOI":"10.1016\/j.phymed.2023.155129","volume":"121","author":"Z Shen","year":"2023","unstructured":"Shen Z, Cui T, Liu Y, Wu S, Han C, Li J. Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the \u201cgut-kidney axis.\u201d Phytomedicine. 2023;121:155129. https:\/\/doi.org\/10.1016\/j.phymed.2023.155129.","journal-title":"Phytomedicine"},{"key":"1426_CR85","doi-asserted-by":"publisher","first-page":"1643515","DOI":"10.3389\/fendo.2025.1643515","volume":"16","author":"H Jiang","year":"2025","unstructured":"Jiang H, Wang X, Zhou W, Huang Z, Zhang W. Gut microbiota-derived short-chain fatty acids mediate the antifibrotic effects of traditional Chinese medicine in diabetic nephropathy. Front Endocrinol. 2025;16:1643515. https:\/\/doi.org\/10.3389\/fendo.2025.1643515.","journal-title":"Front Endocrinol"},{"key":"1426_CR86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12951-024-02447-y","volume":"22","author":"Z Deng","year":"2024","unstructured":"Deng Z, Yang C, Xiang T, Dou C, Sun D, Dai Q, et al. Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the \u201cmicrobiota-gut-joint\u201d axis. J Nanobiotechnol. 2024;22:157. https:\/\/doi.org\/10.1186\/s12951-024-02447-y.","journal-title":"J Nanobiotechnol"},{"key":"1426_CR87","doi-asserted-by":"publisher","first-page":"122275","DOI":"10.1016\/j.carbpol.2024.122275","volume":"339","author":"H Si","year":"2024","unstructured":"Si H, Chen Y, Hu D, Yao S, Yang J, Wen X. A graminan type fructan from Achyranthes bidentata prevents the kidney injury in diabetic mice by regulating gut microbiota. Carbohydr Polym. 2024;339:122275. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122275.","journal-title":"Carbohydr Polym"},{"key":"1426_CR88","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ijbiomac.2022.03.077","volume":"206","author":"M Zhang","year":"2022","unstructured":"Zhang M, Yang L, Zhu M, Yang B, Yang Y, Jia X, et al. Moutan cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats. Int J Biol Macromol. 2022;206:849\u201360. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.03.077.","journal-title":"Int J Biol Macromol"},{"key":"1426_CR89","doi-asserted-by":"publisher","first-page":"1124704","DOI":"10.3389\/fimmu.2023.1124704","volume":"14","author":"Z-H Mao","year":"2023","unstructured":"Mao Z-H, Gao Z-X, Liu D-W, Liu Z-S, Wu P. Gut microbiota and its metabolites \u2013 molecular mechanisms and management strategies in diabetic kidney disease. Front Immunol. 2023;14:1124704. https:\/\/doi.org\/10.3389\/fimmu.2023.1124704.","journal-title":"Front Immunol"},{"key":"1426_CR90","doi-asserted-by":"publisher","first-page":"151408","DOI":"10.1016\/j.semnephrol.2023.151408","volume":"43","author":"K Sumida","year":"2023","unstructured":"Sumida K, Pierre JF, Yuzefpolskaya M, Colombo PC, Demmer RT, Kovesdy CP. Gut microbiota-targeted interventions in the management of chronic kidney disease. Semin Nephrol. 2023;43:151408. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151408.","journal-title":"Semin Nephrol"},{"key":"1426_CR91","doi-asserted-by":"publisher","first-page":"2506810","DOI":"10.1080\/0886022X.2025.2506810","volume":"47","author":"C Li","year":"2025","unstructured":"Li C, Chen X, Zha W, Fang S, Shen J, Li L, et al. Impact of gut microbiota in chronic kidney disease: natural polyphenols as beneficial regulators. Ren Fail. 2025;47:2506810. https:\/\/doi.org\/10.1080\/0886022X.2025.2506810.","journal-title":"Ren Fail"},{"key":"1426_CR92","doi-asserted-by":"publisher","first-page":"155492","DOI":"10.1016\/j.phymed.2024.155492","volume":"128","author":"H Wang","year":"2024","unstructured":"Wang H, Zhu W, Hong Y, Wei W, Zheng N, He X, et al. Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism. Phytomedicine. 2024;128:155492. https:\/\/doi.org\/10.1016\/j.phymed.2024.155492.","journal-title":"Phytomedicine"},{"key":"1426_CR93","doi-asserted-by":"publisher","first-page":"124621","DOI":"10.1016\/j.carbpol.2025.124621","volume":"373","author":"MF Karag\u00f6z","year":"2026","unstructured":"Karag\u00f6z MF, \u00dcnald\u0131 B\u00d6, Buhurcu CA, \u015een N, Aydo\u011fdu GS, Demirci K\u015e, et al. Seaweed polysaccharides and their potential health effects via gut microbiota modulation. Carbohyd Polym. 2026;373:124621. https:\/\/doi.org\/10.1016\/j.carbpol.2025.124621.","journal-title":"Carbohyd Polym"},{"key":"1426_CR94","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/biom15121750","volume":"15","author":"X Sun","year":"2025","unstructured":"Sun X, Li P, Chen B, Chen C, Zhao J, Sun S. Fucoidan therapy for extraintestinal diseases: targeting the microbiota\u2013gut\u2013organ axes. Biomolecules. 2025;15:1750. https:\/\/doi.org\/10.3390\/biom15121750.","journal-title":"Biomolecules"},{"key":"1426_CR95","doi-asserted-by":"publisher","first-page":"154775","DOI":"10.1016\/j.phymed.2023.154775","volume":"114","author":"Z Yi","year":"2023","unstructured":"Yi Z, Peng Y-J, Hui B, Liu Z, Lin Q, Zhao D, et al. Zuogui-jiangtang-yishen decoction prevents diabetic kidney disease: intervene pyroptosis induced by trimethylamine N-oxide through the mROS-NLRP3 axis. Phytomedicine. 2023;114:154775. https:\/\/doi.org\/10.1016\/j.phymed.2023.154775.","journal-title":"Phytomedicine"},{"key":"1426_CR96","doi-asserted-by":"publisher","first-page":"113159","DOI":"10.1016\/j.biopha.2022.113159","volume":"152","author":"T Liu","year":"2022","unstructured":"Liu T, Lu X, Gao W, Zhai Y, Li H, Li S, et al. Cardioprotection effect of Yiqi\u2013Huoxue\u2013Jiangzhuo formula in a chronic kidney disease mouse model associated with gut microbiota modulation and NLRP3 inflammasome inhibition. Biomed Pharmacother. 2022;152:113159. https:\/\/doi.org\/10.1016\/j.biopha.2022.113159.","journal-title":"Biomed Pharmacother"},{"key":"1426_CR97","doi-asserted-by":"publisher","first-page":"156195","DOI":"10.1016\/j.phymed.2024.156195","volume":"135","author":"H Ge","year":"2024","unstructured":"Ge H, Wei Y, Zhang W, Yong C, Chen Y, Zhou E. Suyin detoxification granule alleviates trimethylamine N-oxide\u2013induced tubular ferroptosis and renal fibrosis to prevent chronic kidney disease progression. Phytomedicine. 2024;135:156195. https:\/\/doi.org\/10.1016\/j.phymed.2024.156195.","journal-title":"Phytomedicine"},{"key":"1426_CR98","doi-asserted-by":"publisher","first-page":"115434","DOI":"10.1016\/j.biopha.2023.115434","volume":"166","author":"J Wang","year":"2023","unstructured":"Wang J, Guo X, Zou Z, Yu M, Li X, Xu H, et al. Ootheca mantidis mitigates renal fibrosis in mice by the suppression of apoptosis via increasing the gut microbe Akkermansia muciniphila and modulating glutamine metabolism. Biomed Pharmacother. 2023;166:115434. https:\/\/doi.org\/10.1016\/j.biopha.2023.115434.","journal-title":"Biomed Pharmacother"},{"key":"1426_CR99","doi-asserted-by":"publisher","first-page":"154935","DOI":"10.1016\/j.phymed.2023.154935","volume":"118","author":"T Lan","year":"2023","unstructured":"Lan T, Tang T, Li Y, Duan Y, Yuan Q, Liu W, et al. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis. Phytomedicine. 2023;118:154935. https:\/\/doi.org\/10.1016\/j.phymed.2023.154935.","journal-title":"Phytomedicine"},{"key":"1426_CR100","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41401-018-0029-3","volume":"40","author":"J Zhao","year":"2019","unstructured":"Zhao J, Zhang Q, Shen J, Wang K, Liu J. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin. 2019;40:507\u201313. https:\/\/doi.org\/10.1038\/s41401-018-0029-3.","journal-title":"Acta Pharmacol Sin"},{"key":"1426_CR101","doi-asserted-by":"publisher","first-page":"105444","DOI":"10.1016\/j.phrs.2021.105444","volume":"165","author":"Q Hu","year":"2021","unstructured":"Hu Q, Zhang W, Wu Z, Tian X, Xiang J, Li L, et al. Baicalin and the liver-gut system: pharmacological bases explaining its therapeutic effects. Pharmacol Res. 2021;165:105444. https:\/\/doi.org\/10.1016\/j.phrs.2021.105444.","journal-title":"Pharmacol Res"},{"key":"1426_CR102","doi-asserted-by":"publisher","first-page":"110325","DOI":"10.1016\/j.biopha.2020.110325","volume":"129","author":"T Zhao","year":"2020","unstructured":"Zhao T, Zhang H, Yin X, Zhao H, Ma L, Yan M, et al. Tangshen formula modulates gut microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomed Pharmacother. 2020;129:110325. https:\/\/doi.org\/10.1016\/j.biopha.2020.110325.","journal-title":"Biomed Pharmacother"},{"key":"1426_CR103","doi-asserted-by":"publisher","first-page":"e70861","DOI":"10.1096\/fj.202501201R","volume":"39","author":"K Sun","year":"2025","unstructured":"Sun K, Huang F, Xie W, Hu W, Zhu M, Fan Z, et al. Xiaoyu Xiezhuo decoction ameliorates tubulointerstitial fibrosis by modulating gut-kidney axis and aldosterone signaling pathway in UUO rats. FASEB J. 2025;39:e70861. https:\/\/doi.org\/10.1096\/fj.202501201R.","journal-title":"FASEB J"},{"key":"1426_CR104","doi-asserted-by":"publisher","first-page":"156677","DOI":"10.1016\/j.phymed.2025.156677","volume":"141","author":"Y Ni","year":"2025","unstructured":"Ni Y, Yang W, Wang S, Pan Y, Du H, Zheng L, et al. Modified huangfeng decoction alleviates diabetic nephropathy by activating autophagy and regulating the gut microbiota. Phytomedicine. 2025;141:156677. https:\/\/doi.org\/10.1016\/j.phymed.2025.156677.","journal-title":"Phytomedicine"},{"key":"1426_CR105","doi-asserted-by":"publisher","first-page":"1578400","DOI":"10.3389\/fphar.2025.1578400","volume":"16","author":"L Li","year":"2025","unstructured":"Li L, Zou J, Zhou T, Liu X, Tan D, Xiang Q, et al. mTOR-mediated nutrient sensing and oxidative stress pathways regulate autophagy: A key mechanism for traditional Chinese medicine to improve diabetic kidney disease. Front Pharmacol. 2025;16:1578400. https:\/\/doi.org\/10.3389\/fphar.2025.1578400.","journal-title":"Front Pharmacol"},{"key":"1426_CR106","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13020-024-01004-x","volume":"19","author":"W Wang","year":"2024","unstructured":"Wang W, Dai R, Cheng M, Chen Y, Gao Y, Hong X, et al. Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play? Chin Med. 2024;19:148. https:\/\/doi.org\/10.1186\/s13020-024-01004-x.","journal-title":"Chin Med"},{"key":"1426_CR107","first-page":"2464","volume":"30","author":"B Shui","year":"2015","unstructured":"Shui B, Wen C, Fan Y, Ding X. Study of Jieduquyuziyin prescription on intestinal microbiota in systemic lupus erythematosus mice. CJTCMP. 2015;30:2464\u20139.","journal-title":"CJTCMP"},{"key":"1426_CR108","first-page":"4944","volume":"33","author":"Z He","year":"2018","unstructured":"He Z, Xie D, Liu Q, Yu Y, Wen C, Mao Y. Comparison of effects on gut microbiome by Jiedu Quyu Ziyin Formula or prednisone in MRL\/lpr mice. CJTCMP. 2018;33:4944\u20137.","journal-title":"CJTCMP"},{"key":"1426_CR109","first-page":"2033","volume":"36","author":"Q Liu","year":"2021","unstructured":"Liu Q, Wang M, Lin X, Li H, Wen C, He Z. Effects of early difference gut microbiota in treating MRL\/lpr mice by Jiedu Quyu Ziyin Decoction. CJTCMP. 2021;36:2033\u20137.","journal-title":"CJTCMP"},{"key":"1426_CR110","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1039\/D5FO01743B","volume":"16","author":"F Huang","year":"2025","unstructured":"Huang F, Sun K, Diao L, Lu K, Fan Y, Xie G. Glycyrrhizin alleviates renal damage in MRL\/lpr mice by modulating gut microbiota dysbiosis and regulating the RTK-PKC\u03b1 axis: insights from reverse network pharmacology. Food Funct. 2025;16:7717\u201333. https:\/\/doi.org\/10.1039\/D5FO01743B.","journal-title":"Food Funct"},{"key":"1426_CR111","first-page":"6743","volume":"36","author":"X Lin","year":"2021","unstructured":"Lin X, Yu Y, Liu Q, He Z, Li H, Wen C. Regulating effect of Qinghao-Biejia on gut microbiota in the treatment of MRL\/lpr mice. CJTCMP. 2021;36:6743\u20136.","journal-title":"CJTCMP"},{"key":"1426_CR112","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1080\/10408398.2020.1850417","volume":"62","author":"LT Marton","year":"2022","unstructured":"Marton LT, Barbalho SM, Sloan KP, Sloan LA, Goulart RDA, Ara\u00fajo AC, et al. Curcumin, autoimmune and inflammatory diseases: going beyond conventional therapy \u2013 a systematic review. Crit Rev Food Sci Nutr. 2022;62:2140\u201357. https:\/\/doi.org\/10.1080\/10408398.2020.1850417.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1426_CR113","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/nu11051004","volume":"11","author":"M Yang","year":"2019","unstructured":"Yang M, Akbar U, Mohan C. Curcumin in autoimmune and rheumatic diseases. Nutrients. 2019;11:1004. https:\/\/doi.org\/10.3390\/nu11051004.","journal-title":"Nutrients"},{"key":"1426_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"AA Momtazi-Borojeni","year":"2018","unstructured":"Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili S-A, Johnston TP, Abdollahi E, Sahebkar A. Curcumin: a natural modulator of immune cells in systemic Lupus erythematosus. Autoimmun Rev. 2018;17:125\u201335. https:\/\/doi.org\/10.1016\/j.autrev.2017.11.016.","journal-title":"Autoimmun Rev"},{"key":"1426_CR115","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/09612033231161961","volume":"32","author":"N Ramessar","year":"2023","unstructured":"Ramessar N, Borad A, Schlesinger N. The impact of curcumin supplementation on systemic Lupus erythematosus and Lupus nephritis: a systematic review. Lupus. 2023;32:644\u201357. https:\/\/doi.org\/10.1177\/09612033231161961.","journal-title":"Lupus"},{"key":"1426_CR116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59:89\u2013101. https:\/\/doi.org\/10.1080\/10408398.2017.1358139.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1426_CR117","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/ijms21051745","volume":"21","author":"T Wu","year":"2020","unstructured":"Wu T, Marakkath B, Ye Y, Khobahy E, Yan M, Hutcheson J, et al. Curcumin attenuates both acute and chronic immune nephritis. Int J Mol Sci. 2020;21:1745. https:\/\/doi.org\/10.3390\/ijms21051745.","journal-title":"Int J Mol Sci"},{"key":"1426_CR118","doi-asserted-by":"publisher","first-page":"e001220","DOI":"10.1136\/lupus-2024-001220","volume":"11","author":"H Yang","year":"2024","unstructured":"Yang H, Zhang H, Tian L, Guo P, Liu S, Chen H, et al. Curcumin attenuates Lupus nephritis by inhibiting neutrophil migration via PI3K\/AKT\/NF-\u03baB signalling pathway. Lupus Sci Med. 2024;11:e001220. https:\/\/doi.org\/10.1136\/lupus-2024-001220.","journal-title":"Lupus Sci Med"},{"key":"1426_CR119","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/ptr.7417","volume":"36","author":"S Chamani","year":"2022","unstructured":"Chamani S, Moossavi M, Naghizadeh A, Abbasifard M, Majeed M, Johnston TP, et al. Immunomodulatory effects of curcumin in systemic autoimmune diseases. Phytother Res. 2022;36:1616\u201332. https:\/\/doi.org\/10.1002\/ptr.7417.","journal-title":"Phytother Res"},{"key":"1426_CR120","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.intimp.2019.01.046","volume":"69","author":"J Zhao","year":"2019","unstructured":"Zhao J, Wang J, Zhou M, Li M, Li M, Tan H. Curcumin attenuates murine Lupus via inhibiting NLRP3 inflammasome. Int Immunopharmacol. 2019;69:213\u20136. https:\/\/doi.org\/10.1016\/j.intimp.2019.01.046.","journal-title":"Int Immunopharmacol"},{"key":"1426_CR121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00394-024-03515-7","volume":"64","author":"S Sedighi","year":"2025","unstructured":"Sedighi S, Faramarzipalangar Z, Mohammadi E, Aghamohammadi V, Bahnemiri MG, Mohammadi K. The effects of curcumin supplementation on inflammatory markers in systemic Lupus erythematosus patients: a randomized placebo-controlled trial. Eur J Nutr. 2025;64:8. https:\/\/doi.org\/10.1007\/s00394-024-03515-7.","journal-title":"Eur J Nutr"},{"key":"1426_CR122","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11926-013-0378-3","volume":"15","author":"CM Greco","year":"2013","unstructured":"Greco CM, Nakajima C, Manzi S. Updated review of complementary and alternative medicine treatments for systemic Lupus erythematosus. Curr Rheumatol Rep. 2013;15:378. https:\/\/doi.org\/10.1007\/s11926-013-0378-3.","journal-title":"Curr Rheumatol Rep"},{"key":"1426_CR123","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.jrn.2011.03.002","volume":"22","author":"P Khajehdehi","year":"2012","unstructured":"Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr. 2012;22:50\u20137. https:\/\/doi.org\/10.1053\/j.jrn.2011.03.002.","journal-title":"J Ren Nutr"},{"key":"1426_CR124","doi-asserted-by":"publisher","first-page":"102933","DOI":"10.1016\/j.cis.2023.102933","volume":"318","author":"R Chang","year":"2023","unstructured":"Chang R, Chen L, Qamar M, Wen Y, Li L, Zhang J, et al. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems. Adv Colloid Interface Sci. 2023;318:102933. https:\/\/doi.org\/10.1016\/j.cis.2023.102933.","journal-title":"Adv Colloid Interface Sci"},{"key":"1426_CR125","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","volume":"80","author":"W Weng","year":"2022","unstructured":"Weng W, Goel A. Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Semin Cancer Biol. 2022;80:73\u201386. https:\/\/doi.org\/10.1016\/j.semcancer.2020.02.011.","journal-title":"Semin Cancer Biol"},{"key":"1426_CR126","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1080\/10408398.2018.1478388","volume":"59","author":"L Shen","year":"2019","unstructured":"Shen L, Ji H-F. Bidirectional interactions between dietary curcumin and gut microbiota. Crit Rev Food Sci Nutr. 2019;59:2896\u2013902. https:\/\/doi.org\/10.1080\/10408398.2018.1478388.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1426_CR127","doi-asserted-by":"publisher","first-page":"110270","DOI":"10.1016\/j.foodres.2021.110270","volume":"143","author":"S Li","year":"2021","unstructured":"Li S, You J, Wang Z, Liu Y, Wang B, Du M, et al. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice. Food Res Int. 2021;143:110270. https:\/\/doi.org\/10.1016\/j.foodres.2021.110270.","journal-title":"Food Res Int"},{"key":"1426_CR128","doi-asserted-by":"publisher","first-page":"154979","DOI":"10.1016\/j.phymed.2023.154979","volume":"119","author":"H Cheng","year":"2023","unstructured":"Cheng H, Zhang D, Wu J, Liu J, Zhou Y, Tan Y, et al. Interactions between gut microbiota and polyphenols: a mechanistic and metabolomic review. Phytomedicine. 2023;119:154979. https:\/\/doi.org\/10.1016\/j.phymed.2023.154979.","journal-title":"Phytomedicine"},{"key":"1426_CR129","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1080\/10408398.2023.2204349","volume":"64","author":"T Qin","year":"2024","unstructured":"Qin T, Chen X, Meng J, Guo Q, Xu S, Hou S, et al. The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective. Crit Rev Food Sci Nutr. 2024;64:8822\u201351. https:\/\/doi.org\/10.1080\/10408398.2023.2204349.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1426_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C. Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed. 2024;5:42. https:\/\/doi.org\/10.1186\/s43556-024-00207-w.","journal-title":"Mol Biomed"},{"key":"1426_CR131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2019.12.004","volume":"147","author":"S Cao","year":"2020","unstructured":"Cao S, Wang C, Yan J, Li X, Wen J, Hu C. Curcumin ameliorates oxidative stress-induced intestinal barrier injury and mitochondrial damage by promoting parkin dependent mitophagy through AMPK-TFEB signal pathway. Free Radic Biol Med. 2020;147:8\u201322. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.12.004.","journal-title":"Free Radic Biol Med"},{"key":"1426_CR132","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.7150\/ijbs.72283","volume":"18","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li C, Liu M, Song Z, Moyer MP, Su D. The low-density lipoprotein receptor-related protein 6 pathway in the treatment of intestinal barrier dysfunction induced by hypoxia and intestinal microbiota through the wnt\/\u03b2-catenin pathway. Int J Biol Sci. 2022;18:4469\u201381. https:\/\/doi.org\/10.7150\/ijbs.72283.","journal-title":"Int J Biol Sci"},{"key":"1426_CR133","doi-asserted-by":"publisher","first-page":"120719","DOI":"10.1016\/j.jep.2025.120719","volume":"355","author":"H Yang","year":"2026","unstructured":"Yang H, Wang J, Xie J, Yang H, Wu X. Molecular mechanisms and delivery strategies of celastrol targeting inflammation-associated autoimmune diseases. J Ethnopharmacol. 2026;355:120719. https:\/\/doi.org\/10.1016\/j.jep.2025.120719.","journal-title":"J Ethnopharmacol"},{"key":"1426_CR134","doi-asserted-by":"publisher","first-page":"110651","DOI":"10.1016\/j.cbi.2023.110651","volume":"382","author":"D Cui","year":"2023","unstructured":"Cui D, Xu D, Yue S, Yan C, Liu W, Fu R, et al. Recent advances in the pharmacological applications and liver toxicity of triptolide. Chem Biol Interact. 2023;382:110651. https:\/\/doi.org\/10.1016\/j.cbi.2023.110651.","journal-title":"Chem Biol Interact"},{"key":"1426_CR135","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","volume":"16","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Zhao Y, Zheng Y. Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity. Chin Med. 2021;16:114. https:\/\/doi.org\/10.1186\/s13020-021-00525-z.","journal-title":"Chin Med"},{"key":"1426_CR136","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1631\/jzus.B1900607","volume":"21","author":"C Song","year":"2020","unstructured":"Song C, Xu Y, Lu Y. Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B. 2020;21:280\u201390. https:\/\/doi.org\/10.1631\/jzus.B1900607.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1426_CR137","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10067-022-06400-y","volume":"42","author":"D Shi","year":"2023","unstructured":"Shi D, Li Y, Shi X, Yao M, Wu D, Zheng Y, et al. Transcriptional expression of CXCL10 and STAT1 in lupus nephritis and the intervention effect of triptolide. Clin Rheumatol. 2023;42:539\u201348. https:\/\/doi.org\/10.1007\/s10067-022-06400-y.","journal-title":"Clin Rheumatol"},{"key":"1426_CR138","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/life13071589","volume":"13","author":"A Pasdaran","year":"2023","unstructured":"Pasdaran A, Hassani B, Tavakoli A, Kozuharova E, Hamedi A. A review of the potential benefits of herbal medicines, small molecules of natural sources, and supplements for health promotion in lupus conditions. Life (Basel). 2023;13:1589. https:\/\/doi.org\/10.3390\/life13071589.","journal-title":"Life (Basel)"},{"key":"1426_CR139","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3389\/fphar.2019.01469","volume":"10","author":"K Yuan","year":"2019","unstructured":"Yuan K, Li X, Lu Q, Zhu Q, Jiang H, Wang T, et al. Application and mechanisms of triptolide in the treatment of inflammatory diseases\u2014a review. Front Pharmacol. 2019;10:1469. https:\/\/doi.org\/10.3389\/fphar.2019.01469.","journal-title":"Front Pharmacol"},{"key":"1426_CR140","doi-asserted-by":"publisher","first-page":"671","DOI":"10.19852\/j.cnki.jtcm.2022.05.001","volume":"42","author":"Z Yingyan","year":"2022","unstructured":"Yingyan Z, Huasheng L, Jingyao Y, Xiaohong H, Lili P, Xue L, et al. Effectiveness and safety of tripterygium glycosides tablet for lupus nephritis: a systematic review and meta-analysis. J Tradit Chin Med. 2022;42:671\u201380. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2022.05.001.","journal-title":"J Tradit Chin Med"},{"key":"1426_CR141","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5603\/FHC.a2022.0020","volume":"60","author":"G Xiang","year":"2022","unstructured":"Xiang G, Shi K, Wang J. Celastrol alleviates murine lupus nephritis via inducting CD4+Foxp3+ regulatory T cells. Folia Histochem Cytobiol. 2022;60:237\u201346. https:\/\/doi.org\/10.5603\/FHC.a2022.0020.","journal-title":"Folia Histochem Cytobiol"},{"key":"1426_CR142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fmed.2017.00069","volume":"4","author":"R Casc\u00e3o","year":"2017","unstructured":"Casc\u00e3o R, Fonseca JE, Moita LF. Celastrol: a spectrum of treatment opportunities in chronic diseases. Front Med. 2017;4:69. https:\/\/doi.org\/10.3389\/fmed.2017.00069.","journal-title":"Front Med"},{"key":"1426_CR143","doi-asserted-by":"publisher","first-page":"105572","DOI":"10.1016\/j.phrs.2021.105572","volume":"167","author":"S Xu","year":"2021","unstructured":"Xu S, Feng Y, He W, Xu W, Xu W, Yang H, et al. Celastrol in metabolic diseases: progress and application prospects. Pharmacol Res. 2021;167:105572. https:\/\/doi.org\/10.1016\/j.phrs.2021.105572.","journal-title":"Pharmacol Res"},{"key":"1426_CR144","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.gpb.2022.05.002","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, Guo W, Dong Y, Wang W, Tian C, Zhang Z, et al. Beneficial effects of celastrol on immune balance by modulating gut microbiota in experimental ulcerative colitis mice. Genomics Proteomics Bioinformatics. 2022;20:288\u2013303. https:\/\/doi.org\/10.1016\/j.gpb.2022.05.002.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1426_CR145","doi-asserted-by":"publisher","first-page":"157172","DOI":"10.1016\/j.phymed.2025.157172","volume":"147","author":"M Hu","year":"2025","unstructured":"Hu M, Yang J, Chen Y, Zhang Y, Liu C-H, Feng Y, et al. Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway. Phytomedicine. 2025;147:157172. https:\/\/doi.org\/10.1016\/j.phymed.2025.157172.","journal-title":"Phytomedicine"},{"key":"1426_CR146","doi-asserted-by":"publisher","first-page":"102077","DOI":"10.1016\/j.isci.2021.102077","volume":"24","author":"H Hua","year":"2021","unstructured":"Hua H, Zhang Y, Zhao F, Chen K, Wu T, Liu Q, et al. Celastrol inhibits intestinal lipid absorption by reprofiling the gut microbiota to attenuate high-fat diet-induced obesity. iScience. 2021;24:102077. https:\/\/doi.org\/10.1016\/j.isci.2021.102077.","journal-title":"iScience"},{"key":"1426_CR147","doi-asserted-by":"publisher","first-page":"1124240","DOI":"10.3389\/fphar.2023.1124240","volume":"14","author":"D Zeng","year":"2023","unstructured":"Zeng D, Zhang L, Luo Q. Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXR\u03b1 in vivo and in vitro. Front Pharmacol. 2023;14:1124240. https:\/\/doi.org\/10.3389\/fphar.2023.1124240.","journal-title":"Front Pharmacol"},{"key":"1426_CR148","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4093\/dmj.2019.0124","volume":"44","author":"W Hu","year":"2020","unstructured":"Hu W, Wang L, Du G, Guan Q, Dong T, Song L, et al. Effects of microbiota on the treatment of obesity with the natural product celastrol in rats. Diabetes Metab J. 2020;44:747\u201363. https:\/\/doi.org\/10.4093\/dmj.2019.0124.","journal-title":"Diabetes Metab J"},{"key":"1426_CR149","doi-asserted-by":"publisher","first-page":"119042","DOI":"10.1016\/j.ecoenv.2025.119042","volume":"304","author":"J Zhang","year":"2025","unstructured":"Zhang J, Dai X, Mao J, Yan L, Ren L, Li J, et al. Natural compound library screening identifies triptolide for the treatment of okadaic acid-induced intestinal dysfunction. Ecotoxicol Environ Saf. 2025;304:119042. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.119042.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1426_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.045","author":"J Bi","year":"2025","unstructured":"Bi J, Yang Y, Li M, Lu H, Chen B, Pan X, et al. Tripterygium wilfordii multi-glycoside alleviates ankylosing spondylitis via gut microbiota modulation and metabolite reprogramming. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.11.045.","journal-title":"J Adv Res"},{"key":"1426_CR151","doi-asserted-by":"publisher","first-page":"1236272","DOI":"10.3389\/fcimb.2023.1236272","volume":"13","author":"X Zhan","year":"2023","unstructured":"Zhan X, Zuo Q, Huang G, Qi Z, Wang Y, Zhu S, et al. Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer. Front Cell Infect Microbiol. 2023;13:1236272. https:\/\/doi.org\/10.3389\/fcimb.2023.1236272.","journal-title":"Front Cell Infect Microbiol"},{"key":"1426_CR152","doi-asserted-by":"publisher","first-page":"946030","DOI":"10.3389\/fphar.2022.946030","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Chen S, Zhang J, Wu J. Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases. Front Pharmacol. 2022;13:946030. https:\/\/doi.org\/10.3389\/fphar.2022.946030.","journal-title":"Front Pharmacol"},{"key":"1426_CR153","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41419-019-1315-9","volume":"10","author":"J Yang","year":"2019","unstructured":"Yang J, Yang X, Yang J, Li M. Baicalin ameliorates lupus autoimmunity by inhibiting differentiation of tfh cells and inducing expansion of tfr cells. Cell Death Dis. 2019;10:140. https:\/\/doi.org\/10.1038\/s41419-019-1315-9.","journal-title":"Cell Death Dis"},{"key":"1426_CR154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-019-1876-0","volume":"21","author":"D Li","year":"2019","unstructured":"Li D, Shi G, Wang J, Zhang D, Pan Y, Dou H, et al. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells. Arthritis Res Ther. 2019;21:105. https:\/\/doi.org\/10.1186\/s13075-019-1876-0.","journal-title":"Arthritis Res Ther"},{"key":"1426_CR155","doi-asserted-by":"publisher","first-page":"156049","DOI":"10.1016\/j.phymed.2024.156049","volume":"135","author":"T Hu","year":"2024","unstructured":"Hu T, Zhu Y, Zhou X, Ye M, Wang X, Lu C, et al. Baicalein ameliorates SEB-induced acute respiratory distress syndrome in a microbiota-dependent manner. Phytomedicine. 2024;135:156049. https:\/\/doi.org\/10.1016\/j.phymed.2024.156049.","journal-title":"Phytomedicine"},{"key":"1426_CR156","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.ecoenv.2024.116832","volume":"283","author":"J Li","year":"2024","unstructured":"Li J, Liu Y, He J, Yao W. Baicalin ameliorates heat stress-induced hepatic injury and intestinal microecology dysbiosis in late gestational mice. Ecotoxicol Environ Saf. 2024;283:116832. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116832.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1426_CR157","doi-asserted-by":"publisher","first-page":"107194","DOI":"10.1016\/j.phrs.2024.107194","volume":"204","author":"S Zhang","year":"2024","unstructured":"Zhang S, Tang S, Liu Z, Lv H, Cai X, Zhong R, et al. Baicalin restore intestinal damage after early-life antibiotic therapy: the role of the MAPK signaling pathway. Pharmacol Res. 2024;204:107194. https:\/\/doi.org\/10.1016\/j.phrs.2024.107194.","journal-title":"Pharmacol Res"},{"key":"1426_CR158","doi-asserted-by":"publisher","first-page":"1599570","DOI":"10.3389\/fimmu.2025.1599570","volume":"16","author":"P Ren","year":"2025","unstructured":"Ren P, Zhao Y, Li X, Xie J, Liao X, Luo Q, et al. Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behaviour in atherosclerotic mice by inhibiting nerve cell ferroptosis. Front Immunol. 2025;16:1599570. https:\/\/doi.org\/10.3389\/fimmu.2025.1599570.","journal-title":"Front Immunol"},{"key":"1426_CR159","doi-asserted-by":"publisher","first-page":"155233","DOI":"10.1016\/j.phymed.2023.155233","volume":"124","author":"H Hu","year":"2024","unstructured":"Hu H, Yao Y, Liu F, Luo L, Liu J, Wang X, et al. Integrated microbiome and metabolomics revealed the protective effect of baicalin on alveolar bone inflammatory resorption in aging. Phytomedicine. 2024;124:155233. https:\/\/doi.org\/10.1016\/j.phymed.2023.155233.","journal-title":"Phytomedicine"},{"key":"1426_CR160","doi-asserted-by":"publisher","first-page":"113892","DOI":"10.1016\/j.isci.2025.113892","volume":"28","author":"Z Miao","year":"2025","unstructured":"Miao Z, Long J, Huang B, Yan D, Wang A. Roseburia hominis enriched by baicalin reverses the non-response to metformin via upregulating linolenic acid metabolism<\/Text>. iScience. 2025;28:113892. https:\/\/doi.org\/10.1016\/j.isci.2025.113892.","journal-title":"iScience"},{"key":"1426_CR161","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107452.","journal-title":"Pharmacol Ther"},{"key":"1426_CR162","doi-asserted-by":"publisher","first-page":"932874","DOI":"10.3389\/fphar.2022.932874","volume":"13","author":"X Gong","year":"2022","unstructured":"Gong X, Li H, Guo H, Wu S, Lu C, Chen Y, et al. Efficacy and safety of total glucosides of paeony in the treatment of systemic lupus erythematosus: a systematic review and meta-analysis. Front Pharmacol. 2022;13:932874. https:\/\/doi.org\/10.3389\/fphar.2022.932874.","journal-title":"Front Pharmacol"},{"key":"1426_CR163","doi-asserted-by":"publisher","first-page":"113708","DOI":"10.1016\/j.jep.2020.113708","volume":"269","author":"P Li","year":"2021","unstructured":"Li P, Shen J, Wang Z, Liu S, Liu Q, Li Y, et al. Genus Paeonia: a comprehensive review on traditional uses, phytochemistry, pharmacological activities, clinical application, and toxicology. J Ethnopharmacol. 2021;269:113708. https:\/\/doi.org\/10.1016\/j.jep.2020.113708.","journal-title":"J Ethnopharmacol"},{"key":"1426_CR164","doi-asserted-by":"publisher","first-page":"834947","DOI":"10.3389\/fphar.2022.834947","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang L, Cao Y, Li N. Total glucosides of Paeonia lactiflora for safely reducing disease activity in systemic lupus erythematosus: a systematic review and meta-analysis. Front Pharmacol. 2022;13:834947. https:\/\/doi.org\/10.3389\/fphar.2022.834947.","journal-title":"Front Pharmacol"},{"key":"1426_CR165","doi-asserted-by":"publisher","first-page":"683249","DOI":"10.3389\/fimmu.2021.683249","volume":"12","author":"C-L Liang","year":"2021","unstructured":"Liang C-L, Jiang H, Feng W, Liu H, Han L, Chen Y, et al. Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands+ macrophages via activating IL-4\/STAT6\/PD-L2 signaling. Front Immunol. 2021;12:683249. https:\/\/doi.org\/10.3389\/fimmu.2021.683249.","journal-title":"Front Immunol"},{"key":"1426_CR166","doi-asserted-by":"publisher","first-page":"156996","DOI":"10.1016\/j.phymed.2025.156996","volume":"145","author":"Y Wang","year":"2025","unstructured":"Wang Y, He Q-Q, Zhu Y-T, Zhang Y, Yan J, Liang L-F, et al. Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes. Phytomedicine. 2025;145:156996. https:\/\/doi.org\/10.1016\/j.phymed.2025.156996.","journal-title":"Phytomedicine"},{"key":"1426_CR167","doi-asserted-by":"publisher","first-page":"112913","DOI":"10.1016\/j.jep.2020.112913","volume":"258","author":"H Jiang","year":"2020","unstructured":"Jiang H, Li J, Wang L, Wang S, Nie X, Chen Y, et al. Total glucosides of paeony: a review of its phytochemistry, role in autoimmune diseases, and mechanisms of action. J Ethnopharmacol. 2020;258:112913. https:\/\/doi.org\/10.1016\/j.jep.2020.112913.","journal-title":"J Ethnopharmacol"},{"key":"1426_CR168","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fphar.2019.00057","volume":"10","author":"J Tu","year":"2019","unstructured":"Tu J, Guo Y, Hong W, Fang Y, Han D, Zhang P, et al. The regulatory effects of paeoniflorin and its derivative paeoniflorin-6\u2032-O-benzene sulfonate CP-25 on inflammation and immune diseases. Front Pharmacol. 2019;10:57. https:\/\/doi.org\/10.3389\/fphar.2019.00057.","journal-title":"Front Pharmacol"},{"key":"1426_CR169","doi-asserted-by":"publisher","first-page":"114434","DOI":"10.1016\/j.bcp.2021.114434","volume":"185","author":"C-L Liang","year":"2021","unstructured":"Liang C-L, Lu W, Qiu F, Li D, Liu H, Zheng F, et al. Paeoniflorin ameliorates murine lupus nephritis by increasing CD4+Foxp3+ treg cells via enhancing mTNF\u03b1-TNFR2 pathway. Biochem Pharmacol. 2021;185:114434. https:\/\/doi.org\/10.1016\/j.bcp.2021.114434.","journal-title":"Biochem Pharmacol"},{"key":"1426_CR170","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fcimb.2019.00204","volume":"9","author":"J Peng","year":"2019","unstructured":"Peng J, Lu X, Xie K, Xu Y, He R, Guo L, et al. Dynamic alterations in the gut microbiota of collagen-induced arthritis rats following the prolonged administration of total glucosides of paeony. Front Cell Infect Microbiol. 2019;9:204. https:\/\/doi.org\/10.3389\/fcimb.2019.00204.","journal-title":"Front Cell Infect Microbiol"},{"key":"1426_CR171","doi-asserted-by":"publisher","first-page":"113039","DOI":"10.1016\/j.intimp.2024.113039","volume":"142","author":"Q Hu","year":"2024","unstructured":"Hu Q, Xie J, Jiang T, Gao P, Chen Y, Zhang W, et al. Paeoniflorin alleviates DSS-induced ulcerative colitis by suppressing inflammation, oxidative stress, and apoptosis via regulating serum metabolites and inhibiting CDC42\/JNK signaling pathway. Int Immunopharmacol. 2024;142:113039. https:\/\/doi.org\/10.1016\/j.intimp.2024.113039.","journal-title":"Int Immunopharmacol"},{"key":"1426_CR172","doi-asserted-by":"publisher","first-page":"e101979","DOI":"10.1136\/gpsych-2024-101979","volume":"38","author":"S Zhang","year":"2025","unstructured":"Zhang S, Pan D, Chen S, Tang D, Yang H, Song D, et al. Paeoniflorin ameliorates depressive behaviours by modulating microbiota\u2013gut\u2013brain axis functions. Gen Psychiatry. 2025;38:e101979. https:\/\/doi.org\/10.1136\/gpsych-2024-101979.","journal-title":"Gen Psychiatry"},{"key":"1426_CR173","doi-asserted-by":"publisher","first-page":"e00990","DOI":"10.1128\/msystems.00990-25","volume":"10","author":"M Xia","year":"2025","unstructured":"Xia M, Jiang Z, Li B, Liang Y, Zhao H, Xie D, et al. Paeoniflorin improves atherosclerosis by regulating the gut microbiota and fecal metabolites. mSystems. 2025;10:e00990. https:\/\/doi.org\/10.1128\/msystems.00990-25.","journal-title":"mSystems"},{"key":"1426_CR174","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s10753-019-01085-z","volume":"42","author":"X-X Wu","year":"2019","unstructured":"Wu X-X, Huang X-L, Chen R-R, Li T, Ye H-J, Xie W, et al. Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide (LPS)-induced inflammation in caco-2 cell monolayers. Inflammation. 2019;42:2215\u201325. https:\/\/doi.org\/10.1007\/s10753-019-01085-z.","journal-title":"Inflammation"},{"key":"1426_CR175","doi-asserted-by":"publisher","first-page":"166885","DOI":"10.1016\/j.scitotenv.2023.166885","volume":"904","author":"X Pei","year":"2023","unstructured":"Pei X, Tang S, Jiang H, Zhang W, Xu G, Zuo Z, et al. Paeoniflorin recued hepatotoxicity under zinc oxide nanoparticles exposure via regulation on gut-liver axis and reversal of pyroptosis. Sci Total Environ. 2023;904:166885. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.166885.","journal-title":"Sci Total Environ"},{"key":"1426_CR176","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13020-020-00342-w","volume":"15","author":"W-W Lu","year":"2020","unstructured":"Lu W-W, Fu T-X, Wang Q, Chen Y-L, Li T-Y, Wu G-L. The effect of total glucoside of paeony on gut microbiota in NOD mice with Sj\u00f6gren\u2019s syndrome based on high-throughput sequencing of 16SrRNA gene. Chin Med. 2020;15:61. https:\/\/doi.org\/10.1186\/s13020-020-00342-w.","journal-title":"Chin Med"},{"key":"1426_CR177","doi-asserted-by":"publisher","first-page":"153345","DOI":"10.1016\/j.phymed.2020.153345","volume":"79","author":"Q Fan","year":"2020","unstructured":"Fan Q, Guan X, Hou Y, Liu Y, Wei W, Cai X, et al. Paeoniflorin modulates gut microbial production of indole-3-lactate and epithelial autophagy to alleviate colitis in mice. Phytomedicine. 2020;79:153345. https:\/\/doi.org\/10.1016\/j.phymed.2020.153345.","journal-title":"Phytomedicine"},{"key":"1426_CR178","doi-asserted-by":"publisher","first-page":"153590","DOI":"10.1016\/j.phymed.2021.153590","volume":"87","author":"X-Y Cao","year":"2021","unstructured":"Cao X-Y, Ni J-H, Wang X, Feng G-Z, Li H-D, Bao W-L, et al. Total glucosides of paeony restores intestinal barrier function through inhibiting lyn\/snail signaling pathway in colitis mice. Phytomedicine. 2021;87:153590. https:\/\/doi.org\/10.1016\/j.phymed.2021.153590.","journal-title":"Phytomedicine"},{"key":"1426_CR179","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","volume":"68","author":"J An","year":"2017","unstructured":"An J, Minie M, Sasaki T, Woodward JJ, Elkon KB. Antimalarial drugs as immune modulators: new mechanisms for old drugs. Annu Rev Med. 2017;68:317\u201330. https:\/\/doi.org\/10.1146\/annurev-med-043015-123453.","journal-title":"Annu Rev Med"},{"key":"1426_CR180","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1111\/bph.70086","volume":"182","author":"F Zhou","year":"2025","unstructured":"Zhou F, Li G, Tan R, Wu G, Deng C. Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis. Br J Pharmacol. 2025;182:3411\u201327. https:\/\/doi.org\/10.1111\/bph.70086.","journal-title":"Br J Pharmacol"},{"key":"1426_CR181","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-018-0764-y","volume":"20","author":"X Mu","year":"2018","unstructured":"Mu X, Wang C. Artemisinins\u2014a promising new treatment for systemic lupus erythematosus: a descriptive review. Curr Rheumatol Rep. 2018;20:55. https:\/\/doi.org\/10.1007\/s11926-018-0764-y.","journal-title":"Curr Rheumatol Rep"},{"key":"1426_CR182","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","volume":"166","author":"L Hou","year":"2016","unstructured":"Hou L, Huang H. Immune suppressive properties of artemisinin family drugs. Pharmacol Ther. 2016;166:123\u20137. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.002.","journal-title":"Pharmacol Ther"},{"key":"1426_CR183","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/med.21842","volume":"41","author":"T Efferth","year":"2021","unstructured":"Efferth T, Oesch F. The immunosuppressive activity of artemisinin\u2010type drugs towards inflammatory and autoimmune diseases. Med Res Rev. 2021;41:3023\u201361. https:\/\/doi.org\/10.1002\/med.21842.","journal-title":"Med Res Rev"},{"key":"1426_CR184","doi-asserted-by":"publisher","first-page":"1097206","DOI":"10.3389\/fphar.2023.1097206","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Chen D, Yang L, Mao H, Ma F, et al. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases. Front Pharmacol. 2023;14:1097206. https:\/\/doi.org\/10.3389\/fphar.2023.1097206.","journal-title":"Front Pharmacol"},{"key":"1426_CR185","doi-asserted-by":"publisher","first-page":"111462","DOI":"10.1016\/j.intimp.2023.111462","volume":"127","author":"X Lu","year":"2024","unstructured":"Lu X, Huang Y, Zhou M, Guo Y, Zhou Y, Wang R, et al. Artesunate attenuates serum amyloid a-induced M1 macrophage differentiation through the promotion of PHGDH. Int Immunopharmacol. 2024;127:111462. https:\/\/doi.org\/10.1016\/j.intimp.2023.111462.","journal-title":"Int Immunopharmacol"},{"key":"1426_CR186","doi-asserted-by":"publisher","first-page":"152965","DOI":"10.1016\/j.phymed.2019.152965","volume":"62","author":"W-Z Dang","year":"2019","unstructured":"Dang W-Z, Li H, Jiang B, Nandakumar KS, Liu K-F, Liu L-X, et al. Therapeutic effects of artesunate on lupus-prone MRL\/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2\u2013STAT3 signaling pathway. Phytomedicine. 2019;62:152965. https:\/\/doi.org\/10.1016\/j.phymed.2019.152965.","journal-title":"Phytomedicine"},{"key":"1426_CR187","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12272-024-01505-1","volume":"47","author":"X Shi","year":"2024","unstructured":"Shi X, Liao T, Chen Y, Chen J, Liu Y, Zhao J, et al. Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment. Arch Pharmacal Res. 2024;47:632\u201344. https:\/\/doi.org\/10.1007\/s12272-024-01505-1.","journal-title":"Arch Pharmacal Res"},{"key":"1426_CR188","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11427-019-9550-4","volume":"63","author":"T Zhang","year":"2020","unstructured":"Zhang T, Zhang Y, Jiang N, Zhao X, Sang X, Yang N, et al. Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses. Sci China Life Sci. 2020;63:737\u201349. https:\/\/doi.org\/10.1007\/s11427-019-9550-4.","journal-title":"Sci China Life Sci"},{"key":"1426_CR189","doi-asserted-by":"publisher","first-page":"103915","DOI":"10.1016\/j.bioorg.2020.103915","volume":"100","author":"Z Lei","year":"2020","unstructured":"Lei Z, Yang Y, Liu S, Lei Y, Yang L, Zhang X, et al. Dihydroartemisinin ameliorates Dextran Sulfate Sodium induced inflammatory bowel diseases in mice. Bioorg Chem. 2020;100:103915. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103915.","journal-title":"Bioorg Chem"},{"key":"1426_CR190","doi-asserted-by":"publisher","first-page":"112699","DOI":"10.1016\/j.intimp.2024.112699","volume":"139","author":"Y Li","year":"2024","unstructured":"Li Y, Shan Y, Xu L, Chen W, Li Y. Dihydroartemisinin ameliorates experimental autoimmune Myasthenia Gravis by regulating CD4+ T cells and modulating gut microbiota. Int Immunopharmacol. 2024;139:112699. https:\/\/doi.org\/10.1016\/j.intimp.2024.112699.","journal-title":"Int Immunopharmacol"},{"key":"1426_CR191","doi-asserted-by":"publisher","first-page":"2403461","DOI":"10.1002\/advs.202403461","volume":"11","author":"P Qiu","year":"2024","unstructured":"Qiu P, Chang Y, Chen X, Wang S, Nie H, Hong Y, et al. Dihydroartemisinin modulates enteric glial cell heterogeneity to alleviate colitis. Adv Sci. 2024;11:2403461. https:\/\/doi.org\/10.1002\/advs.202403461.","journal-title":"Adv Sci"},{"key":"1426_CR192","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/mmr.2020.11165","volume":"22","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Lei Y, Yang L, Zhang X, Yuan J, et al. Effects of dihydroartemisinin on the gut microbiome of mice. Mol Med Rep. 2020;22:707\u201314. https:\/\/doi.org\/10.3892\/mmr.2020.11165.","journal-title":"Mol Med Rep"},{"key":"1426_CR193","doi-asserted-by":"publisher","first-page":"109687","DOI":"10.1016\/j.jnutbio.2024.109687","volume":"131","author":"Y Guo","year":"2024","unstructured":"Guo Y, Chen Y, Wang D, Liu G, Chen Y, Peng C, et al. Artemisinin and its derivatives modulate glucose homeostasis and gut microbiota remodeling in a nutritional context. J Nutr Biochem. 2024;131:109687. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109687.","journal-title":"J Nutr Biochem"},{"key":"1426_CR194","doi-asserted-by":"publisher","first-page":"e70235","DOI":"10.1111\/1751-7915.70235","volume":"18","author":"H Han","year":"2025","unstructured":"Han H, Li Y, Wang L, Jin Z, Zhou W, Zhang B, et al. Liver\u2013microbiome crosstalk mediates the protective effects of artemisinin in Clostridium perfringens models. Microb Biotechnol. 2025;18:e70235. https:\/\/doi.org\/10.1111\/1751-7915.70235.","journal-title":"Microb Biotechnol"},{"key":"1426_CR195","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13238-020-00784-w","volume":"12","author":"T-L Lin","year":"2021","unstructured":"Lin T-L, Lu C-C, Lai W-F, Wu T-S, Lu J-J, Chen Y-M, et al. Role of gut microbiota in identification of novel TCM-derived active metabolites. Protein Cell. 2021;12:394\u2013410. https:\/\/doi.org\/10.1007\/s13238-020-00784-w.","journal-title":"Protein Cell"},{"key":"1426_CR196","doi-asserted-by":"publisher","first-page":"123738","DOI":"10.1016\/j.biomaterials.2025.123738","volume":"327","author":"M Liu","year":"2026","unstructured":"Liu M, Li X, Gao Y, Wei Z, Ma J, Zhang L, et al. Breaking the fibrotic code: nanotechnology-driven advances in renal fibrosis therapy. Biomaterials. 2026;327:123738. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123738.","journal-title":"Biomaterials"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01426-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:18:26Z","timestamp":1779866306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01426-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":196,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1426"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01426-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I confirm we have the right to publish this work and have obtained all required permissions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}